Gene · 563
Papers1,833
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
421 to 440 of 1,833
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Protein signatures to distinguish aggressive from indolent prostate cancer. | Prostate | 2022 | 35098564 | PubTator, text mining | PubMed |
| The tyrosine kinase inhibitor LPM4870108 impairs learning and memory and induces transcriptomic and gene‑specific DNA methylation changes in rats. | Arch Toxicol | 2022 | 35098321 | PubTator, text mining | PubMed |
| Circulating levels of urocortin neuropeptides are impaired in children with overweight. | Obesity (Silver Spring) | 2022 | 35088550 | PubTator, text mining | PubMed |
| Analysis of plasma proteins using 2D gels and novel fluorescent probes: in search of blood based biomarkers for Alzheimer's disease. | Proteome Sci | 2022 | 35081972 | PubTator, text mining | PubMed |
| Plasma protein biomarker model for screening Alzheimer disease using multiple reaction monitoring-mass spectrometry. | Sci Rep | 2022 | 35075217 | PubTator, text mining | PubMed |
| Prognostic Genomic Tissue-Based Biomarkers in the Treatment of Localized Prostate Cancer. | J Pers Med | 2022 | 35055380 | PubTator, text mining | PubMed |
| The Therapeutic Potential of Zinc-Alpha2-Glycoprotein (AZGP1) in Fibrotic Kidney Disease. | Int J Mol Sci | 2022 | 35054830 | PubTator, text mining | PubMed |
| Integrated single-cell RNA sequencing analysis reveals distinct cellular and transcriptional modules associated with survival in lung cancer. | Signal Transduct Target Ther | 2022 | 35027529 | PubTator, text mining | PubMed |
| Identification of Serum Biomarkers in Patients with Alzheimer's Disease by 2D-DIGE Proteomics. | Gerontology | 2022 | 35021178 | PubTator, text mining | PubMed |
| Circulating Tumor Cell Transcriptomics as Biopsy Surrogates in Metastatic Breast Cancer. | Ann Surg Oncol | 2022 | 35000083 | PubTator, text mining | PubMed |
| Meta-analysis of whole-genome gene expression datasets assessing the effects of IDH1 and IDH2 mutations in isogenic disease models. | Sci Rep | 2022 | 34997121 | PubTator, text mining | PubMed |
| Transcriptomics of receptive endometrium in women with sonographic features of adenomyosis. | Reprod Biol Endocrinol | 2022 | 34980152 | PubTator, text mining | PubMed |
Methoxy-Monobenzoylmethane Protects Skin from UV-Induced Damages in a Randomized, Placebo Controlled, Double-Blinded Human In Vivo Study and Prevents Signs of Inflammation While Improving the Skin Barrier. | Dermatol Ther (Heidelb) | 2022 | 34939179 | PubTator, text mining | PubMed |
| Microcystin-leucine arginine exposure induced intestinal lipid accumulation and MC-LR efflux disorder in Lithobates catesbeianus tadpoles. | Toxicology | 2022 | 34863901 | PubTator, text mining | PubMed |
| Molecular mechanism of albumin in suppressing invasion and metastasis of hepatocellular carcinoma. | Liver Int | 2022 | 34854209 | PubTator, text mining | PubMed |
| Identification of diverse lipid-binding modes in the groove of zinc α2 glycoprotein reveals its functional versatility. | FEBS J | 2022 | 34817923 | PubTator, text mining | PubMed |
| Impact of computational approaches in the fight against COVID-19: an AI guided review of 17 000 studies. | Brief Bioinform | 2022 | 34788381 | PubTator, text mining | PubMed |
| Comparison of risk assessment in 1652 early ER positive, HER2 negative breast cancer in a real-world data set: classical pathological parameters vs. 12-gene molecular assay (EndoPredict). | Breast Cancer Res Treat | 2022 | 34783927 | PubTator, text mining | PubMed |
| Dexamethasone modulates immature neutrophils and interferon programming in severe COVID-19. | Nat Med | 2022 | 34782790 | PubTator, text mining | PubMed |
| Extracellular vesicles: The key for precision medicine in glioblastoma. | Neuro Oncol | 2022 | 34581817 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/563/papers?page=22